In their study, deletion of BRCA2 in murine prostatic epithelia led to focal hyperplasia and low-grade prostate epithelial neoplasia (PIN) in animals aged over 12 months. This evidence concerns the gene BRCA2 and prostate intraepithelial neoplasia.